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Abstract
There has been a lack of consistency in detecting chromosomal loci that are linked to obesity-
related traits. This may be due, in part, to the phenotype definition. Many studies use a one-time,
single measurement as a phenotype while one's weight often fluctuates considerably throughout
adulthood. Longitudinal data from the Framingham Heart Study were used to derive alternative
phenotypes that may lead to more consistent findings. Body mass index (BMI), a measurement for
obesity, is known to increase with age and then plateau or decline slightly; the decline phase may
represent a threshold or survivor effect. We propose to use the weight gain phase of BMI to derive
phenotypes useful for linkage analysis of obesity. Two phenotypes considered in the present study
are the average of and the slope of the BMI measurements in the gain phase (gain mean and gain
slope). For comparison, we also considered the average of all BMI measurements available (overall
mean). Linkage analysis using the gain mean phenotype exhibited two markers with LOD scores
greater than 3, with the largest score of 3.52 on chromosome 4 at ATA2A03. In contrast, no LOD
scores greater than 3 were observed when overall mean was used. The gain slope produced weak
evidence for linkage on chromosome 4 with a multipoint LOD score of 1.77 at GATA8A05. Our
analysis shows how omitting the decline phase of BMI in the definition of obesity phenotypes can
result in evidence for linkage which might have been otherwise overlooked.
Background
Body mass index (BMI = weight (kg)/height2 (m)) is a
commonly used estimate of adiposity that correlates well
with more direct and invasive measures of percentage
body fat. Since height and weight are collected in many
studies, the convenience and cost-effectiveness of using
BMI leads to its use as a quantitative trait in linkage stud-
ies of obesity. Unfortunately, finding the chromosomal
locations of genes responsible for controlling BMI has
proven difficult [1]. The current study hypothesizes that
the lack of consistency may reflect the large variability in
the phenotype definition, since many studies use a single
measurement of BMI that may fluctuate considerably
throughout adulthood.
The phenotypic definition of obesity is often a result of
the study design, leaving little choice for more robust
alternatives. Study designs for quantitative trait locus
(QTL) mapping of BMI-related phenotypes vary substan-
tially, from longitudinal [2-4] to cross-sectional [5]
designs. BMI-based phenotypes include the maximum
observed value [3], the last value observed [4], the only
value observed [5], and the value at a specific age [2]. The
populations considered in different studies may also dif-
fer, concentrating for example on a young population [3],
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that is known to exhibit a high prevalence of type 2 diabe-
tes mellitus [3]. The longitudinal data from the Framing-
ham Heart Study can help determine more robust
phenotypic definitions of BMI for use in genetic studies
whether they be longitudinal or cross-sectional in design.
In a technical report by (Bellhouse DR, Chipman HA, and
Stafford JE, 2002) from the Ontario Health Study (OHS),
analysis of cross-sectional survey data provided significant
evidence of a nonlinear association between BMI and age,
characterized by an increasing phase to approximately age
55 followed by a slight decline as subjects aged. The
decline phase may reflect both a survivor effect as well as
a true threshold effect. The existence of such a nonlinear
relationship between BMI and age implies that, for studies
of obesity-related traits, any phenotype that incorporate
BMI measurements across the whole age range (gain and
decline phases), whether they be cross-sectional pheno-
types (a mean or single measurement) or longitudinal (a
slope), would be biased by the decline phase. As an alter-
native, we derive two obesity phenotypes based on BMI
measurements in the gain phase only (gain mean and gain
slope) and evaluate them in a genome-wide linkage
analysis.
Methods
The Framingham Heart Study data, supplied to the partic-
ipants of Genetic Analysis Workshop 13, was used to
explore longitudinal BMI as a phenotype for genetic anal-
ysis. Observations taken when age < 18 years were
excluded. The data indicated a nonlinear relationship
between age and BMI, one quite similar to that described
in the OHS. Plots of individuals' BMI by age exhibited the
existence of a consistent nonlinear profile within individ-
uals. Figure 1 illustrates the cross-sectional and longitudi-
nal aspect of the general relationship between BMI and
age observed in the data, as well as the variability of indi-
vidual measurements.
Within individuals, on average, BMI increased from age
18 until age 53 and then began to decline or stabilize.
Depending on the age range of the individual during data
collection, different components of this profile might be
seen. For this reason and to address issues of nonlinearity,
each individual's BMI by age profile was summarized by
two phases: a gain phase and a decline phase, demarcated by
the observed age at maximum BMI. One could then define
BMI phenotypes derived solely from an individual's gain
phase, which would then have a simple linear relationship
with age. Two such possibilities would be 1) a cross-sec-
tional phenotype defined as the average of the BMI meas-
urements in the gain phase, gain mean, measuring the
tendency to be heavier-set, and 2) a longitudinal pheno-
type, the slope in the gain phase, gain slope, measuring the
rate of weight gain.
The gain slope for an individual was calculated as the coef-
ficient for age from a simple linear model, regressing BMI
on age, with the data restricted to that observed in the
individual's gain phase. Thus, both the gain mean and the
gain slope utilized the longitudinal nature of the data to
obtain more reliable measures of cross-sectional and lon-
gitudinal BMI phenotypes for obesity-related traits.
For individuals to have a measurement for gain mean and
gain slope, it was required that they have at least three BMI
measurements in their gain phase. This choice was arbi-
trary and made by the authors in an attempt to reduce the
noise in the measurements while still ensuring sufficient
subjects were included in the analysis. If a height measure-
ment was missing at a particular visit for an individual
whose data would otherwise be complete at that visit,
height was imputed from other visits. Specifically, the
measurement from the closest gain phase visit, with
height information available, was used.
A natural log transformation was used to achieve approx-
imate normality for the phenotypic distributions. The her-
itability and significance of covariate information in the
additive genetic model for the gain mean and gain slope
were evaluated and then QTL mapping using SOLAR 1.6.7
[6] was used to perform additive variance component
two-point linkage analyses. Information content for the
markers was calculated using GENEHUNTER (version
2.1_r2 beta) [7]. Heritability calculations, covariate
screening, and linkage analysis were also performed on
the overall mean, a BMI phenotype defined as the average
of all the BMI measurements including the decline phase
of the individuals. Approximate multipoint linkage anal-
yses [6] of the gain slope and gain mean phenotypes were
also conducted. All genetic models used for linkage anal-
ysis included gender, cohort (whether they came from the
original Cohort 1 or the offspring Cohort 2 of the Fram-
ingham Heart Study data, where Cohort 2 was generally
younger with fewer visits) and the cohort-by-gender inter-
action. The two-point LOD scores from the linkage analy-
ses of gain mean and overall mean were compared to
evaluate the utility of omitting the decline phase when
defining a BMI phenotype.
Results
Table 1 provides descriptive statistics for the age at maxi-
mum BMI, the gain slope, the gain mean, and the overall
mean. The majority of subjects in the study were defined
to have both gain phase phenotypes (N = 2226 of 2878
for whom BMI data was available in 330 pedigrees); 375
individuals had only a decline phase, with their maxi-
mum BMI measurement at their first observation; 277Page 2 of 6
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The BMI relationship with age Cross-sectional and longitudinal BMI by age relationship (a) raw data sample of 5000 obser-
vations with lowess smoother and regression line (b) individual profiles in one family superimposed on the lowess smoother 
from (a).
Table 1: Summary statistics for the derived phenotypes and age at maximum BMI
Phenotype 1st Quartile Median Mean 3rd Quartile Standard 
Deviation
Sample Size
age max BMI 44.00 52.00 52.78 63.00 13.52 2878
gain slope 0.08 0.16 0.19 0.26 0.17 2226
gain mean 23.63 25.99 26.48 28.54 4.23 2226
overall mean 23.36 25.81 26.26 28.42 4.29 2878Page 3 of 6
(page number not for citation purposes)
BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S14individuals had only one BMI measurement before their
age at maximum BMI. The gain slope appeared quite varia-
ble across individuals. The distributions of gain mean and
overall mean were quite similar. The variability of the age
at maximum BMI was large (i.e., large standard deviation).
All the phenotypic models, accounting for the covariates,
displayed significant heritability, with the heritability
(standard error) for the gain slope, gain mean, and overall
mean equal to 0.11 (0.04), 0.49 (0.04), and 0.49 (0.03),
respectively.
All markers exhibiting two-point LOD scores greater than
2 for gain mean or overall mean are listed in Table 2 with
their flanking marker information in parentheses. The
information content for the markers is also provided. For
each of the markers listed in the table, the LOD score for
gain mean was larger than that for overall mean. There were
two markers for gain mean with LOD scores greater than 3,
the largest being 3.52 located on chromosome 4 at 93 cM.
The largest two-point LOD score observed for overall mean
was 2.49 on chromosome 9 at 92 cM. The LOD score at
this marker for gain mean was 3.14.
The two-point evidence of linkage for the gain slope was
weak, with only four markers across the genome exhibit-
ing LOD scores greater than 1, the largest being 1.29 on
chromosome 4 at 158 cM. However, three of these mark-
ers were in the same general region on chromosome 4
(130 cM, 143 cM, and 158 cM). Table 3 lists the two-point
LOD scores, map locations and information content for
these three markers, with the flanking marker results in
parentheses. Due to the additional flanking marker evi-
dence of weak linkage for the gain slope and the lack of evi-
dence at locations in any other region or on any other
chromosome, approximate multipoint analysis was also
performed. The multipoint analysis produced larger LOD
scores on chromosome 4 with the largest LOD score being
1.77 at 174 cM. The multipoint results for the gain slope on
chromosome 4 are illustrated in Figure 2.
Figure 2 also provides the multipoint results for the gain
mean phenotype on chromosome 4 and the information
content across this chromosome. The largest multipoint
result for the gain mean was also on chromosome 4 with a
LOD score of 2.64 at 105 cM. The multipoint results for
the gain mean phenotype on chromosome 9, the other
chromosome that provided a two-point LOD score for the
gain mean that was greater than 3, are illustrated in Figure
3 along with the information content across this chromo-
some. The largest multipoint LOD score on this
chromosome was 2.48 at 100 cM. The multipoint LOD
scores for the gain mean phenotype were smaller than
those observed in the two-point analysis. The information
content across chromosomes 4 and 9 was low (less than
0.52 for all markers on each of these chromosomes).
Discussion
The gain slope, gain mean and overall mean, were shown to
be significantly heritable, with the phenotypes based on
mean values exhibiting much larger heritability estimates
than the gain slope. The most apparent gain from
considering the nonlinear relationship in the definition of
the BMI phenotype can be seen in the comparison of LOD
scores for gain mean and overall mean. Namely, it appears
that linkage analysis based on the gain mean phenotype
Table 2: Two-point linkage results for the cross-sectional BMI phenotypes
Chr # Marker Gain Mean LOD 
Score
Overall Mean LOD 
Score
Location (cM) Information 
Content
4 ATA2A03 3.52 (0.96,0.42) 1.98 (0.40,0.70) 93 (88,105) 0.43 (0.46,0.47)
8 GATA23D06 2.60 (0.27,1.53) 1.82 (0.00,0.22) 26 (22,37) 0.51 (0.51,0.46)
9 GATA81C04 2.28 (0.09,3.14) 1.78 (0.37,2.49) 89 (80,92) 0.48 (0.51,0.47)
9 183xh10 3.14 (2.28,0.28) 2.49 (1.78,0.08) 92 (89,104) 0.47 (0.48,0.43)
11 157xh6 2.36 (0.45,0.00) 0.49 (0.25,0.00) 131 (123,147) 0.46 (0.46,0.13)
Only those markers exhibiting LOD scores greater than 2 are listed in the table; their flanking marker information is in parentheses.
Table 3: Two-point linkage results on chromosome 4 for the gain slope
Marker Gain Slope LOD Score Location (cM) Information Content
ATA26B08 1.03 (0.30,1.09) 130 (114,143) 0.45 (0.46,0.51)
GATA11E09 1.09 (1.03,0.47) 143 (130,146) 0.51 (0.45,0.50)
GATA8A05 1.29 (0.47,0.32) 158 (146,168) 0.43 (0.50,0.45)
All markers on chromosome 4 exhibiting a LOD score greater than 1 are listed in the table with the flanking marker information in parentheses.Page 4 of 6
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encing an individual's tendency to be heavier-set, while
the analysis using the overall mean phenotype (including
both gain and decline phases) did not produce strong
linkage evidence at these potential locations. The gain
mean phenotype provided two regions with two-point
LOD scores greater than 3 with no such regions for the
overall mean phenotype. The proximity of the two elevated
LODs for the adjacent markers on chromosome 9 pro-
vided additional evidence that this location is worthy of
future study. Moreover, the use of the gain mean pheno-
type detected chromosomal locations that have already
been implicated in previous studies using more direct
measures of the obesity phenotype.
The Québec Family Study [8], a genome-wide scan, found
nine QTLs affecting abdominal subcutaneous fat, two of
which were on chromosomes 4 and 9. The region on chro-
mosome 9 reported in Table 2 is the same region (D9S257
at 92 cM) reported in the Québec Family Study to influ-
ence abdominal subcutaneous fat.
A study of Pima Indians [3], who have a high prevalence
of both type 2 diabetes and obesity, performed genome
scans for loci linked to type 2 diabetes and obesity. Vari-
ance components linkage analyses were conducted on
sibships. Phenotypic information came from the partici-
pants of their original longitudinal study, measuring the
age at onset of type 2 diabetes. The mean age at onset of
diabetes among affected offspring was 34 years (SD =
10.6) and the mean age at last examination of nondiabetic
offspring was 35.5 years (SD = 11.1). The maximum BMI
observed in the study period was used as an individual's
BMI phenotype, and the largest associated LOD score was
on chromosome 11 in the same region as that found in
the current study (157xh6 at 131 cM).
Only weak linkage signals were observed in our study for
the gain slope. No chromosomal locations linked to a
slope phenotype were reported in the Human Obesity
Map [1]. However, it is interesting to note that the signals
observed in the current study were in the same general
region on chromosome 4 and did increase in size in the
multipoint analysis. This region is approximately 20 cM,
calculated using the Marshfield Map [9], from the loca-
tion reported for chromosome 4 in the Québec Family
Study [7] (D4S2417), which has been suggested to con-
tain a potential candidate gene.
The only linkage results for obesity reviewed in the
Human Obesity Map [1] that corresponded to the regions
found in the current analysis were those from the Québec
Family Study [8] and the site on chromosome 11 found
by Hanson et al. [3], who studied a relatively young
sample that would, presumably, have not yet entered their
decline phase. A measure such as abdominal subcutane-
ous fat used in the Québec Family Study is a more accurate
measure of obesity. However, such a direct and invasive
measure is only available in studies by design. Accounting
for the nonlinearity of BMI by using the gain mean of BMI,
when longitudinal data is available, seems to be a practi-
cal and simple alternative. The gain mean is not plagued by
Multipoint analysis of both gain phase phenotypes on chromo-some 4Figure 2
Multipoint analysis of both gain phase phenotypes on 
chromosome 4. Multipoint results for the gain slope (in 
red) and the gain mean (in blue) along with the information 
content for this chromosome (in black).
Multipoint analysis of the Gain Mean on Chromosome 9Figure 3
Multipoint analysis of the Gain Mean on chromosome 
9. Multipoint results for the gain mean (in blue) along with 
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the fluctuations of a single cross-sectional measurement
yet it is still easily calculated from the height and weight
data that is often collected in studies with an alternative
focus. The gain mean may also increase the power to detect
linkage to obesity by removing the decline phase of indi-
viduals, which appears to be introducing competing
sources of variation.
In cross-sectional study designs one might incorporate the
results of this study by choosing to restrict BMI pheno-
types on the basis of age; selecting the measurement for
the BMI phenotype to be at ages less than the lower confi-
dence limit for the average age at maximum BMI. The cur-
rent study observed a large standard deviation for the age
at maximum BMI. This may not reflect the true population
standard deviation, because an individual's age at maxi-
mum BMI had to occur at a particular point in time (i.e.,
study visit). Additionally, the data available on some
individuals did not consist of data in both the gain and
decline phases. For example, if data were available for an
individual only in their gain phase then their age at maxi-
mum BMI may have been underestimated. However,
when choosing a BMI phenotype in a cross-sectional
study, with the intent to omit decline phase measure-
ments, the possibility of a large standard deviation in the
age at maximum BMI should be considered.
It is unknown how prevalent the use of a slope phenotype
is for studying obesity-related traits, because there has
been little discussion of these phenotypes in the pub-
lished literature and no slope phenotypes exhibiting
linkage were reported in the Human Obesity Map [1]. The
gain slope may provide a means to distinguish genetic
components controlling the rate of weight gain for an
individual by omitting the decline phase in the definition
of this phenotype. The analysis using the gain slope pheno-
type did suggest a potential region for future study,
although the evidence, as measured by the LOD score, was
weak. Inclusion of the decline phase in the definition of
this phenotype might have led some, who have attempted
to use slope phenotypes in past studies, to overlook this
potential region.
Conclusions
BMI is clearly an accessible surrogate measure for obesity
and is available as a by-product of many studies with an
alternative focus. Exploiting the nonlinearity between
BMI and age to omit the decline phase of individuals in
the definition of the phenotype proved fruitful in the cur-
rent study; the gain mean phenotype exhibited higher
LOD scores than the overall mean phenotype, some at loci
that have already been implicated in a study using a more
direct measure of obesity [8]. Furthermore, the gain slope
phenotype exhibited some weak evidence for linkage
while no such evidence for other obesity slope pheno-
types have been previously reported [1]. The design impli-
cations of this study are, however, the most important
finding. The methodology introduced here may be
generalizable to many traits for which a similar temporal
relationship is known to exist.
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